Logo image of WOK

WORK MEDICAL TECHNOLOGY GR-A (WOK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:WOK - KYG9767H1092 - Common Stock

0.0275 USD
-0.01 (-16.16%)
Last: 12/26/2025, 8:21:45 PM
0.0261 USD
0 (-5.09%)
After Hours: 12/26/2025, 8:21:45 PM
Fundamental Rating

1

WOK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of WOK have multiple concerns. WOK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WOK had negative earnings in the past year.
WOK Yearly Net Income VS EBIT VS OCF VS FCFWOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.06%, WOK is in the better half of the industry, outperforming 61.08% of the companies in the same industry.
Looking at the Return On Equity, with a value of -26.97%, WOK is in line with its industry, outperforming 57.84% of the companies in the same industry.
Industry RankSector Rank
ROA -10.06%
ROE -26.97%
ROIC N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOK Yearly ROA, ROE, ROICWOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

WOK has a worse Gross Margin (24.93%) than 78.38% of its industry peers.
WOK's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for WOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
WOK Yearly Profit, Operating, Gross MarginsWOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

WOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WOK has more shares outstanding
Compared to 1 year ago, WOK has a worse debt to assets ratio.
WOK Yearly Shares OutstandingWOK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50K 100K
WOK Yearly Total Debt VS Total AssetsWOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

WOK has an Altman-Z score of 0.32. This is a bad value and indicates that WOK is not financially healthy and even has some risk of bankruptcy.
WOK's Altman-Z score of 0.32 is in line compared to the rest of the industry. WOK outperforms 44.86% of its industry peers.
A Debt/Equity ratio of 1.00 indicates that WOK is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.00, WOK is doing worse than 74.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC3.91%
WOK Yearly LT Debt VS Equity VS FCFWOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 1.14 indicates that WOK should not have too much problems paying its short term obligations.
WOK has a worse Current ratio (1.14) than 86.49% of its industry peers.
A Quick Ratio of 0.98 indicates that WOK may have some problems paying its short term obligations.
WOK has a Quick ratio of 0.98. This is in the lower half of the industry: WOK underperforms 77.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.98
WOK Yearly Current Assets VS Current LiabilitesWOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

WOK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3657.82%.
The Revenue for WOK has decreased by -15.18% in the past year. This is quite bad
The Revenue for WOK have been decreasing by -36.93% on average. This is quite bad
EPS 1Y (TTM)-3657.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOK Yearly Revenue VS EstimatesWOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WOK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WOK Price Earnings VS Forward Price EarningsWOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WOK Per share dataWOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WOK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

WORK MEDICAL TECHNOLOGY GR-A

NASDAQ:WOK (12/26/2025, 8:21:45 PM)

After market: 0.0261 0 (-5.09%)

0.0275

-0.01 (-16.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)02-03 2026-02-03
Inst Owners0.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.60K
Revenue(TTM)11.51M
Net Income(TTM)-3.49M
AnalystsN/A
Price TargetN/A
Short Float %1.87%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B 0
P/tB 0
EV/EBITDA N/A
EPS(TTM)-27.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.06
BVpS12.45
TBVpS11.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.06%
ROE -26.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.93%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)N/A
ROE(3y)-5.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.98
Altman-Z 0.32
F-ScoreN/A
WACC3.91%
ROIC/WACCN/A
Cap/Depr(3y)251.52%
Cap/Depr(5y)N/A
Cap/Sales(3y)31.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3657.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.18%
Revenue growth 3Y-36.93%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1081.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-806.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.83%
OCF growth 3YN/A
OCF growth 5YN/A

WORK MEDICAL TECHNOLOGY GR-A / WOK FAQ

Can you provide the ChartMill fundamental rating for WORK MEDICAL TECHNOLOGY GR-A?

ChartMill assigns a fundamental rating of 1 / 10 to WOK.


What is the valuation status for WOK stock?

ChartMill assigns a valuation rating of 0 / 10 to WORK MEDICAL TECHNOLOGY GR-A (WOK). This can be considered as Overvalued.


How profitable is WORK MEDICAL TECHNOLOGY GR-A (WOK) stock?

WORK MEDICAL TECHNOLOGY GR-A (WOK) has a profitability rating of 1 / 10.


What is the financial health of WORK MEDICAL TECHNOLOGY GR-A (WOK) stock?

The financial health rating of WORK MEDICAL TECHNOLOGY GR-A (WOK) is 1 / 10.